ADMA BIOLOGICS, INC.
For the period ended Dec 31, 2024. Filed Mar 18, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 18, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
| Item 2. | Properties |
|---|
The table below describes our principal facilities as of December 31, 2024:
| Location | Principal Business Activity | Approximate Square Feet | Owned or expiration date of lease |
|---|---|---|---|
| Ramsey, NJ | Corporate Headquarters | 4,200 | December 31, 2026 * |
| Boca Raton, FL | Manufacturing and Administration | 84,462 | Owned |
| Boca Raton, FL | Laboratory and Administration | 44,495 | Owned |
- Pursuant to a shared services agreement, as amended, with Areth, LLC ("Areth") for office, warehouse space and related services pursuant to which the Company pays Areth monthly lease payments of $10,000. Areth is a company controlled by Dr. Jerrold B. Grossman, our Vice Chairman of the Board of Directors, and Adam S. Grossman, our President and Chief Executive Officer.
We also have ten plasma collection centers in leased facilities mainly in the southeastern part of the U.S., which require lease payments through the respective lease terms that expire at various dates through 2033 (see Note 12 to the consolidated financial statements appearing elsewhere in this report).
We believe that our leased and owned properties are adequate to meet our current and future needs.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.